# Johnson & Johnson (JNJ) — Q3-2012 Earnings Results

**Report date:** 2012-10-16 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2012

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Up 1.38%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.25 | N/A | +3.91% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the quarterly results, highlighting strong performance in key areas. They emphasized their commitment to innovation and patient care.

**Key quotes:**

> We are pleased with our performance this quarter, particularly in our pharmaceutical segment.

> Our focus remains on innovation and improving patient outcomes.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

The earnings report indicates that Johnson & Johnson is performing well, especially in its pharmaceutical division, which contributed to the positive EPS surprise. The stock reacted positively, rising 1.38% as investors responded favorably to the earnings beat. However, the lack of guidance leaves some uncertainty about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2012_